Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-24-002773

Chief Legal Officer gave up 558 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Miller Mary · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-17 Shares withheld for taxes : show line 1 in the form −558 $7.87 $4,391 38,125 D
Loading xslF345X05/form4.xml…